Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse Research Advances in What.

Slides:



Advertisements
Similar presentations
Substance Abuse in Greenville County, SC RESULTS OF A 2003 STUDY.
Advertisements

M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Chestnut Health Systems, Normal, IL
Bringing the Full Power of Science to Bear on Drug Abuse & Addiction Drug Abuse & Addiction.
The Epidemiology of Co-Occurring Disorders H. Westley Clark, MD, JD, MPH Director Center for Substance Abuse Treatment Substance Abuse and Mental Health.
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
 William Frank Barker, LPC, MAC Diane Diver, LMSW, CAC II.
Lori L. Phelps California Association for Alcohol/Drug Educators,
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Prevention Research (Children & Adolescents) genetics environment development co-morbidity Prevention Research (Children & Adolescents) genetics environment.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse RESEARCH and TREATMENT Provide.
1 Sampson & Laub (2004). Criminology, 41 (3):
Methamphetamine Thomas E. Freese, Ph.D. Director, Pacific Southwest Addiction Technology Transfer Center Director of Training, UCLA Integrated Substance.
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
NA shell NA shell vPFC mVP VTA NA core NA core dPFC SN dVP Blockade in these regions blocks relapse or reinstatement Drug Seeking Behavior – Motor Subcircuit.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
Alcoholism and Substance Abuse. Focus Alcoholism.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
SBIRT Introduction and Relevance to DGIM Jason Satterfield, PhD SBIRT Collaborative Education Project Funded by SAMHSA/CSAT Grant 1U79TI
Director, National Institute on Drug Abuse National Institute Alcohol
THE CORRELATION BETWEEN NEUROSCIENCE AND THE BIOPSYCHOSOCIAL DISEASE OF ADDICTION Presented by Peter Ninemire, LMSW, LCAC Counseling The Caring Center.
Rural Crime & Justice Center A University Center of Excellence Minot, North Dakota.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Connecting LEGACY PRIMARY CARE and depaul treatment centers
Recovery Oriented Systems of Care in Minnesota
Talking Points for Managers Community Initiative on Depression Mid-America Coalition on Health Care.
NAMI Annual Convention June 19, 2005 “Promoting Mental Health & Recovery from Mental Illness” Eduardo J. Sanchez, M.D., MPH Commissioner, Texas Department.
Chronic Care Management Hypertension Results: Represents Health Disparities Collaborative for Hypertension Overall CAP Results.
From the Monitoring the Future Study Report: The University of Michigan 2012.
Building a Common Vision for Recovery in America Michael T. Flaherty, Ph.D. Pittsburgh, Pennsylvania White House Compassion in Action Roundtable September.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Addiction: It’s a Brain Disease Beyond a Reasonable Doubt.
RAMAR  SINCE 1980, RAMAR HAS BEEN A VITAL PART OF RECOVERY FOR CHRONICALLY ADDICTED RECOVERY FOR CHRONICALLY ADDICTED INDIVIDUALS IN NEED IN SUMMIT COUNTY.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Nora D. Volkow, M.D. Director National Institute on Drug Abuse.
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
The NSDUH Report: National Survey on Drug Use and Health NSDUH Report Sept. 16, 2005 SAMHSA Office of Applied Studies NSDUH National Survey on.
Substance Abuse Prevention Briefing Community Anti-Drug Coalitions of America.
SUBSTANCE ABUSE Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
The Neurobiology of Free Will In National Institute on Drug Abuse
Red Ribbon Week Mrs. Simpkins/2015. The Faces of Addictions You will be shown several pictures depicting the effects that drugs have on your appearance.
John Boffa Chief Medical Officer Public Health Assoc Prof., NDRI A Comprehensive primary health care approach to ICE, alcohol and other drugs John Boffa.
Senate Study Committee on Youth Mental Health and Substance Use Disorders Laura Searcy President-elect National Association f Pediatric Nurse Practitioners.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Advances in science have revolutionized our fundamental views of drug abuse and addiction. Science has come a long way in helping us understand how drugs.
Selected Effects on Brain, Body
1 Medication Development for Treatment of Drug Dependence Donald R. Wesson, MD Consultant, CNS Medications Development Chairman, ASAM Medications Development.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
NATIONAL INSTITUTE ON DRUG ABUSE NIDA NIAAA National Institute Alcohol Abuse and Alcoholism Nora D. Volkow, M.D. Director, National Institute on Drug Abuse.
1 Did You Know 42% of US high school seniors use alcohol.
Chapter 2 Lori L. Phelps California Association for Alcohol/Drug Educators, TRANSDISCIPLINARY FOUNDATION I: UNDERSTANDING ADDICTION Contributors:
Why Mental Health? Professor Anne Lingford-Hughes Professor of Addiction Biology, Imperial College London Consultant Psychiatrist CNWL NHS Foundation Trust.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
There is Hope. Scary Statistics Substance MalesFemales Any Drug Cocaine Marijuana Opiates Methamp hetamine PCP.
FAMILY RECOVERY NETWORK EVENT: What is Substance Abuse Treatment? Patrick Seche, MS, CASAC Strong Recovery Addiction Psychiatry Division Department of.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
Treating DRUG ADDICTION: What Do We Know? What More Should We Do?
screening, brief intervention and referral to treatment
By Jennifer Long Methamphetamine.
screening, brief intervention, and referral to treatment
National Health Reform is Essential
The Burden of Tobacco Use
SBIRT..What should I know?
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Abnormal Psychology Chapter 9 Substance Use Disorders Second Edition
Developing and Using a Referral Network
The Opioid Crisis: What Can Be Done for the Children
The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care  William W. Busse,
Presentation transcript:

Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse Research Advances in What Do They Mean for Recovery?

Biology/Genes Environment DRUG Addiction Brain Mechanisms 1.ADDICTION INVOLVES MULTIPLE FACTORS

2. ADDICTION IS A DEVELOPMENTAL DISEASE starts in adolescence and childhood 2. ADDICTION IS A DEVELOPMENTAL DISEASE starts in adolescence and childhood NIAAA National Epidemiologic Survey on Alcohol and Related Conditions, 2003 % in each age group who develop first- time cannabis use disorder 0.0% 0.2% 0.4% 0.6% 0.8% 1.0% 1.2% 1.4% 1.6% Age Age at cannabis use disorder as per DSM IV

Brain areas where volumes are smaller in adolescents than young adults Source: Sowell, E.R. et al., Nature Neuroscience, 2(10), pp , 1999 Recent Studies Have Shown that Maturation of the Brain’s Gray Matter Moves from Back to Front Recent Studies Have Shown that Maturation of the Brain’s Gray Matter Moves from Back to Front

Healthy Heart Diseased Heart Decreased Heart Metabolism in Heart Disease Patient 3. ADDICTION IS A DISEASE OF THE BRAIN as other diseases it affects the tissue function Control Cocaine Abuser Decreased Brain Metabolism in Drug Abuse Patient Sources: From the laboratories of Drs. N. Volkow and H. Schelbert High Low

Partial Recovery of Brain Dopamine Transporters in Methamphetamine (METH) Abuser After Protracted Abstinence Normal Control METH Abuser (1 month detox) METH Abuser (24 months detox) 0 3 ml/gm Source: Volkow, ND et al., Journal of Neuroscience 21, , ADDICTION CAN BE TREATED

Relapse Rates Are Similar for Drug Dependence And Other Chronic Illnesses Relapse Rates Are Similar for Drug Dependence And Other Chronic Illnesses Drug Dependence Drug Dependence Type I Diabetes Type I Diabetes Hypertension Asthma 40 to 60% 30 to 50% 50 to 70% Source: McLellan, A.T. et al., JAMA, Vol 284(13), October 4, Percent of Patients Who Relapse Addiction Treatment Does Work

Evaluation of A Hypothetical Treatment PreDuring Post Symptom Severity HYPERTENSION PreDuring Post Stage of Treatment Symptom Severity ADDICTION Just Like Hypertension, Addiction Is A Chronic Disease That Requires Continued Care Source: McLellan, AT, Addiction 97, , 2002.

Posterior Hippocampi of London Taxi Drivers Were Significantly Larger Than Those of Controls Posterior Hippocampi of London Taxi Drivers Were Significantly Larger Than Those of Controls Source: Maguire, E.A. et al., PNAS, 97(8), pp , Positive Correlation Between Gray Matter Volume and Time As A Taxi Driver Control Cocaine Abuser

In 2003, An Estimated 21.6 Million Americans Were Dependent On or Abused Any Illicit Drugs or Alcohol But…Only 3.3 Million (15%) Of These Individuals Had Received Some Type of Treatment In the Past Year In 2003, An Estimated 21.6 Million Americans Were Dependent On or Abused Any Illicit Drugs or Alcohol But…Only 3.3 Million (15%) Of These Individuals Had Received Some Type of Treatment In the Past Year Bench Bedside Community

NIDA Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) Research Centers Coordinating Center National Drug Abuse Treatment Clinical Trials Network (CTN) National Drug Abuse Treatment Clinical Trials Network (CTN) CTN Sites

Where Do We Need to Go From Here? Where Do We Need to Go From Here? We Need to… Advance the SCIENCE Erase the STIGMA and to… Erase the STIGMA and to…